SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-020077
Filing Date
2024-05-16
Accepted
2024-05-15 19:02:01
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 23487
2 ex99-1.htm   iXBRL EX-99.1 711334
3 ex99-2.htm EX-99.2 226454
4 ex99-3.htm EX-99.3 24133
5 ex99-4.htm EX-99.4 24055
6 ex99-1_001.jpg GRAPHIC 1953
7 ex99-2_001.jpg GRAPHIC 7492
8 ex99-2_002.jpg GRAPHIC 42768
9 ex99-2_003.jpg GRAPHIC 43985
  Complete submission text file 0001493152-24-020077.txt   4043474

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE aezs-20240331.xsd EX-101.SCH 30248
11 XBRL CALCULATION FILE aezs-20240331_cal.xml EX-101.CAL 50375
12 XBRL DEFINITION FILE aezs-20240331_def.xml EX-101.DEF 79775
13 XBRL LABEL FILE aezs-20240331_lab.xml EX-101.LAB 224770
14 XBRL PRESENTATION FILE aezs-20240331_pre.xml EX-101.PRE 177996
68 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 691360
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 24953139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)